Cargando…

Exploring the role of the complement system, endothelial injury, and microRNAs in thrombotic microangiopathy after kidney transplantation

OBJECTIVE: We investigated whether the recipient’s complement system function, kidney graft endothelial ultrastructural injury, and microRNA (miRNA) expression before transplantation may be associated with the risk of posttransplant de novo thrombotic microangiopathy (TMA). METHODS: Complement syste...

Descripción completa

Detalles Bibliográficos
Autores principales:	Aleš Rigler, Andreja, Večerić-Haler, Željka, Arnol, Miha, Perše, Martina, Boštjančič, Emanuela, Pleško, Jerica, Simčič, Saša, Kojc, Nika
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Retrospective Clinical Research Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7783899/ https://www.ncbi.nlm.nih.gov/pubmed/33372813 http://dx.doi.org/10.1177/0300060520980530

Ejemplares similares

Coronavirus Disease 2019-Associated Thrombotic Microangiopathy: Literature Review
por: Malgaj Vrečko, Marija, et al.
Publicado: (2022)

The Role of Immune-Related miRNAs in the Pathology of Kidney Transplantation
por: Boštjančič, Emanuela, et al.
Publicado: (2021)

Management of Anticoagulant-Related Nephropathy: A Single Center Experience
por: Belčič Mikič, Tanja, et al.
Publicado: (2021)

Cobalt Ferrite Magnetic Nanoparticles for Tracing Mesenchymal Stem Cells in Tissue: A Preliminary Study
por: Večerić-Haler, Željka, et al.
Publicado: (2022)

Renal Tissue miRNA Expression Profiles in ANCA-Associated Vasculitis—A Comparative Analysis
por: Bošnjak, Matic, et al.
Publicado: (2021)

Coronavirus Disease 2019-Associated Thrombotic Microangiopathy
por: Malgaj Vrecko, Marija, et al.
Publicado: (2022)

Early Graft Loss after Kidney Transplantation: Endothelial Dysfunction of Renal Microvasculature
por: Kojc, N., et al.
Publicado: (2018)

Autologous Mesenchymal Stem Cells for Treatment of Chronic Active Antibody-Mediated Kidney Graft Rejection: Report of the Phase I/II Clinical Trial Case Series
por: Večerić-Haler, Željka, et al.
Publicado: (2022)

Uromodulin and microRNAs in Kidney Transplantation—Association with Kidney Graft Function
por: Borštnar, Špela, et al.
Publicado: (2020)

Diagnostic and treatment challenge of unrecognized subacute bacterial endocarditis associated with ANCA-PR3 positive immunocomplex glomerulonephritis: a case report and literature review
por: Bele, D., et al.
Publicado: (2020)

Case Report: Capillary Leak Syndrome With Kidney Transplant Failure Following Autologous Mesenchymal Stem Cell Therapy
por: Večerić-Haler, Željka, et al.
Publicado: (2021)

Cisplatin-Induced Rodent Model of Kidney Injury: Characteristics and Challenges
por: Perše, Martina, et al.
Publicado: (2018)

The Role of IgA in the Pathogenesis of IgA Nephropathy
por: Perše, Martina, et al.
Publicado: (2019)

Multiorgan failure with fatal outcome after stem cell tourism
por: Večerić-Haler, Željka, et al.
Publicado: (2021)

Just Seeing Is Not Enough for Believing: Immunolabelling as Indisputable Proof of SARS-CoV-2 Virions in Infected Tissue
por: Erman, Andreja, et al.
Publicado: (2021)

SARS-CoV-2 Virions or Ubiquitous Cell Structures? Actual Dilemma in COVID-19 Era
por: Frelih, Maja, et al.
Publicado: (2020)

POS-011 PRIMARY ATYPICAL HEMOLYTIC-UREMIC SYNDROME ASSOCIATED WITH COVID-19: A BRIEF REVIEW
por: MALGAJ VREČKO, M., et al.
Publicado: (2022)

Improved Protective Effect of Umbilical Cord Stem Cell Transplantation on Cisplatin-Induced Kidney Injury in Mice Pretreated with Antithymocyte Globulin
por: Večerić-Haler, Željka, et al.
Publicado: (2016)

Complement in Secondary Thrombotic Microangiopathy
por: Palma, Lilian Monteiro Pereira, et al.
Publicado: (2020)

Complement Mediated Endothelial Damage in Thrombotic Microangiopathies
por: Blasco, Miquel, et al.
Publicado: (2022)

Thrombotic microangiopathies assessment: mind the complement
por: Blasco, Miquel, et al.
Publicado: (2020)

Postsurgical Thrombotic Microangiopathy and Deregulated Complement
por: van Herpt, Thijs T. W., et al.
Publicado: (2022)

An updated classification of thrombotic microangiopathies and treatment of complement gene variant-mediated thrombotic microangiopathy
por: Aigner, Christof, et al.
Publicado: (2019)

(Mesenchymal) Stem Cell-Based Therapy in Cisplatin-Induced Acute Kidney Injury Animal Model: Risk of Immunogenicity and Tumorigenicity
por: Večerić-Haler, Ž., et al.
Publicado: (2017)

Complement, thrombotic microangiopathy and disseminated intravascular coagulation
por: Kurosawa, Shinichiro, et al.
Publicado: (2014)

Complement in Thrombotic Microangiopathies: Unraveling Ariadne's Thread Into the Labyrinth of Complement Therapeutics
por: Gavriilaki, Eleni, et al.
Publicado: (2019)

Extra-Renal Manifestations of Complement-Mediated Thrombotic Microangiopathies
por: Hofer, Johannes, et al.
Publicado: (2014)

The potential role of complements in cocaine-induced thrombotic microangiopathy
por: Dejman, Adriana, et al.
Publicado: (2018)

Combination of plasma exchange and haemofiltration for treating thrombotic microangiopathy in children
por: Huang, Jun, et al.
Publicado: (2020)

Therapeutic Complement Targeting in ANCA-Associated Vasculitides and Thrombotic Microangiopathy
por: Novikov, Pavel, et al.
Publicado: (2016)

Eculizumab for complement mediated thrombotic microangiopathy in sickle cell disease
por: Chonat, Satheesh, et al.
Publicado: (2020)

The Syndromes of Thrombotic Microangiopathy: A Critical Appraisal on Complement Dysregulation
por: Timmermans, Sjoerd A. M. E. G., et al.
Publicado: (2021)

Peering into the darkness of drug-induced thrombotic microangiopathy: complement, are you in there?
por: Sabulski, Anthony, et al.
Publicado: (2023)

Complement-Mediated Thrombotic Microangiopathy in Pregnancy: An Educational Case Report
por: Bruno, Valentina, et al.
Publicado: (2023)

Pregnancy in Complement-Mediated Thrombotic Microangiopathy: Maternal and Neonatal Outcomes
por: Haninger-Vacariu, Natalja, et al.
Publicado: (2023)

Thrombotic Microangiopathies
por: Radhi, Mohamed, et al.
Publicado: (2012)

The thrombotic microangiopathies
por: Copelovitch, Lawrence, et al.
Publicado: (2008)

Down‐regulation of microRNAs of the miR‐200 family and up‐regulation of Snail and Slug in inflammatory bowel diseases — hallmark of epithelial−mesenchymal transition
por: Zidar, Nina, et al.
Publicado: (2016)

Complement C5 inhibition reverses bleomycin-induced thrombotic microangiopathy
por: Salhi, Sofiane, et al.
Publicado: (2020)

Complement inhibitor eculizumab in thrombotic microangiopathy: Single‐center case series
por: Vitkauskaitė, Monika, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_rr76a24t0mba6sr6h28efam97b